Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Technology Diagnostics & Research Information Technology Services
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

TSXV:AVCR - Post Discussion

Avricore Health Inc > Co. update
View:
Post by lscfa on Feb 01, 2023 10:28am

Co. update

Steep decline in Q4 margin or was Q1,Q2, Q3 margins overstated?

 

 

Devices

 

 

 

Qtr ending

Deployed

Revenue

Gross Profit

Margin

 

 

 

 

 

Q4 22 (est)

420

1,208,861

132,052

10.9%

Q3 22

166

572,228

215,961

37.7%

Q2 22

53

176,175

56,874

32.3%

Q1 22

53

42,736

15,113

35.4%

 

 

2,000,000

420,000

21.0%

Comment by M1bmx115 on Apr 29, 2023 5:34pm
Their press release makes no mention of gross profit.  It says their subsidiary- Healthtab - made a profit of $420k.
Avricore Health Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities